Recombinant Human etb Protein，His

ETB (Endothelin B receptor) recombinant proteins have emerged as a focal point in biomedical research due to their critical roles in various physiological processes and pathological conditions. The endothelin signaling pathway, particularly involving the ETB receptor, is implicated in many cardiovascular diseases, neurodegenerative disorders, and cancer. Researchers have sought to understand the mechanisms by which ETB contributes to cellular functions such as vasodilation, neurotransmission, and cell proliferation. The production of recombinant ETB proteins allows for detailed study of their structure, function, and interaction with ligands or antagonists, enabling insights into receptor signaling pathways. Moreover, these recombinant proteins serve as valuable tools for drug discovery and therapeutic development, as they can be used in assays to screen potential compounds and elucidate their effects on ETB-mediated signaling. The advancement of recombinant DNA technology and protein expression systems has facilitated the generation of high-quality ETB proteins, providing researchers with the means to explore their biological significance and therapeutic potential in treating diseases linked to endothelin dysregulation. Overall, the study of ETB recombinant proteins not only enhances our understanding of endothelin biology but also opens avenues for targeted therapeutic strategies in various disease contexts.